Clinical Trial

Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this clinical research study is to learn about the safety and effects of BMS-986504 in combination with olaparib in patients with advanced solid tumors with MTAP loss.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-26.
Status change: Not Yet Recruiting → Recruiting 2026-02-23
Trial Details
NCT Number NCT07382544
Lead Sponsor M.D. Anderson Cancer Center
Conditions Advanced Cancer, Solid Tumor
Enrollment 36 participants
Start Date 2026-02-12
Primary Completion 2030-01-31 (estimated)
Study Completion 2032-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-12